Literature DB >> 8662804

Phosphorylation of Ser211 in the chicken progesterone receptor modulates its transcriptional activity.

W Bai1, N L Weigel.   

Abstract

The chicken progesterone receptor has been shown to be phosphorylated in vivo at four major sites. Previous studies have shown that mutation of one of the hormone-dependent phosphorylation sites, Ser530, to alanine decreases the transcriptional activity of the receptor under conditions where ligand is limited. Here, we present evidence for the functional significance of another phosphorylation site, Ser211. Mutation of Ser211 to alanine results in a decrease in the transcriptional activity of the receptor and affects the phosphorylation-dependent decrease in mobility of the receptor in SDS-polyacrylamide gel electrophoresis. The degree of reduction in transcriptional activity is dependent on both the cell type and the reporters used in the studies but is independent of hormone concentration, suggesting that phosphorylation at Ser211 regulates the activity of the receptor through a mechanism distinct from Ser530 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662804     DOI: 10.1074/jbc.271.22.12801

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  A dynamin-like protein, ADL1, is present in membranes as a high-molecular-mass complex in Arabidopsis thaliana.

Authors:  J M Park; S G Kang; K T Pih; H J Jang; H L Piao; H W Yoon; M J Cho; I Hwang
Journal:  Plant Physiol       Date:  1997-10       Impact factor: 8.340

2.  Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.

Authors:  D Chen; P E Pace; R C Coombes; S Ali
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.

Authors:  Manjula Nakka; Irina U Agoulnik; Nancy L Weigel
Journal:  Int J Biochem Cell Biol       Date:  2012-12-25       Impact factor: 5.085

Review 4.  Steroid hormone receptors and their regulation by phosphorylation.

Authors:  N L Weigel
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

5.  Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.

Authors:  Ramesh Narayanan; Abayomi A Adigun; Dean P Edwards; Nancy L Weigel
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

6.  8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein.

Authors:  B G Rowan; N Garrison; N L Weigel; B W O'Malley
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

7.  1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest.

Authors:  Michele N Washington; Jung-Sun Kim; Nancy L Weigel
Journal:  Prostate       Date:  2011-01-01       Impact factor: 4.104

Review 8.  Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation.

Authors:  Robert D Ward; Nancy L Weigel
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

9.  Glucocorticoid receptor phosphorylation differentially affects target gene expression.

Authors:  Weiwei Chen; Thoa Dang; Raymond D Blind; Zhen Wang; Claudio N Cavasotto; Adam B Hittelman; Inez Rogatsky; Susan K Logan; Michael J Garabedian
Journal:  Mol Endocrinol       Date:  2008-05-15

10.  Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.

Authors:  William C Krause; Ayesha A Shafi; Manjula Nakka; Nancy L Weigel
Journal:  Int J Biochem Cell Biol       Date:  2014-07-04       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.